Lang Zhongliang, Chen Tianao, Zhu Shilu, Wu Xizhi, Wu Yongqi, Miao Xiaoping, Wang Qiang, Zhao Liping, Zhu Zhiqiang, Xu Ronald X
Department of Plastic Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, PR China.
School of Biomedical Engineering, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230026, PR China.
Mater Today Bio. 2024 Nov 10;29:101336. doi: 10.1016/j.mtbio.2024.101336. eCollection 2024 Dec.
Cardiovascular disease (CVD) ranks among the leading causes of morbidity and mortality globally, primarily due to arterial occlusive disease. Vascular bypass remains the cornerstone of treatment; however, many patients lack suitable autologous vessels (e.g., saphenous vein) for grafting. Tissue-engineered vascular grafts (TEVGs) provide a viable alternative capable of integrating, remodeling, and repairing host vessels, responding to mechanical and biochemical stimuli. Currently, preparation methods for TEVGs are mainly categorized into scaffold-free and scaffold-based approaches. Scaffold-free methods exhibit comparatively weaker mechanical properties and limited research progress, whereas scaffold-based approaches show more promising applications due to their superior mechanical properties and biocompatibility. This review examines current research progress in materials, fabrication processes, functionalized modifications, cell implantation, and animal and clinical experiments for scaffold-based preparation of TEVGs. By exploring current challenges and future perspectives in this field, we expect to provide new insights into TEVGs development and expedite their clinical applications.
心血管疾病(CVD)是全球发病和死亡的主要原因之一,主要归因于动脉闭塞性疾病。血管搭桥术仍然是治疗的基石;然而,许多患者缺乏适合移植的自体血管(如大隐静脉)。组织工程血管移植物(TEVG)提供了一种可行的替代方案,能够整合、重塑和修复宿主血管,对机械和生化刺激做出反应。目前,TEVG的制备方法主要分为无支架和有支架两种途径。无支架方法的机械性能相对较弱,研究进展有限,而有支架方法由于其优越的机械性能和生物相容性,显示出更有前景的应用。本文综述了基于支架制备TEVG在材料、制造工艺、功能化修饰、细胞植入以及动物和临床试验方面的研究进展。通过探讨该领域当前的挑战和未来前景,我们期望为TEVG的发展提供新的见解,并加速其临床应用。